Keyword: FDA low approval activity

News

Lonza Shares Fall After Deutsche Bank Downgrade

11.01.2011 - Shares in Swiss drugs industry supplier Lonza fell over 4% on Monday after Deutsche Bank analysts downgraded the stock as they expect the strong Swiss franc and a tougher...